BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9853006)

  • 1. In vitro to in vivo extrapolation for trichloroethylene metabolism in humans.
    Lipscomb JC; Fisher JW; Confer PD; Byczkowski JZ
    Toxicol Appl Pharmacol; 1998 Oct; 152(2):376-87. PubMed ID: 9853006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and metabolism of vinyl fluoride in vivo and in vitro.
    Cantoreggi S; Keller DA
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):130-9. PubMed ID: 9073601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450-dependent metabolism of trichloroethylene: interindividual differences in humans.
    Lipscomb JC; Garrett CM; Snawder JE
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):311-8. PubMed ID: 9070354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione conjugation of trichloroethylene in human liver and kidney: kinetics and individual variation.
    Lash LH; Lipscomb JC; Putt DA; Parker JC
    Drug Metab Dispos; 1999 Mar; 27(3):351-9. PubMed ID: 10064565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo disposition of caffeine predicted from hepatic microsomal and hepatocyte data.
    Hayes KA; Brennan B; Chenery R; Houston JB
    Drug Metab Dispos; 1995 Mar; 23(3):349-53. PubMed ID: 7628300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of human in vitro metabolic parameters to explore the risk assessment of hazardous compounds: the case of ethylene dibromide.
    Ploemen JP; Wormhoudt LW; Haenen GR; Oudshoorn MJ; Commandeur JN; Vermeulen NP; de Waziers I; Beaune PH; Watabe T; van Bladeren PJ
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):56-69. PubMed ID: 9073592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.
    Kuperman AV; Kalgutkar AS; Marfat A; Chambers RJ; Liston TE
    Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of trichloroethylene-induced elevation of individual serum bile acids. II. In vitro and in vivo interference by trichloroethylene with bile acid transport in isolated rat hepatocytes.
    Bai CL; Stacey NH
    Toxicol Appl Pharmacol; 1993 Aug; 121(2):296-302. PubMed ID: 8346546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.
    Riley RJ; McGinnity DF; Austin RP
    Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
    Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies on the cytochrome p450-associated metabolism and interaction potential of selegiline between human liver-derived in vitro systems.
    Salonen JS; Nyman L; Boobis AR; Edwards RJ; Watts P; Lake BG; Price RJ; Renwick AB; Gómez-Lechón MJ; Castell JV; Ingelman-Sundberg M; Hidestrand M; Guillouzo A; Corcos L; Goldfarb PS; Lewis DF; Taavitsainen P; Pelkonen O
    Drug Metab Dispos; 2003 Sep; 31(9):1093-102. PubMed ID: 12920164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of human liver-derived in vitro systems to predict the in vivo metabolism and clearance of almokalant.
    Andersson TB; Sjöberg H; Hoffmann KJ; Boobis AR; Watts P; Edwards RJ; Lake BG; Price RJ; Renwick AB; Gómez-Lechón MJ; Castell JV; Ingelman-Sundberg M; Hidestrand M; Goldfarb PS; Lewis DF; Corcos L; Guillouzo A; Taavitsainen P; Pelkonen O
    Drug Metab Dispos; 2001 May; 29(5):712-20. PubMed ID: 11302938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity.
    Carlile DJ; Hakooz N; Houston JB
    Drug Metab Dispos; 1999 Apr; 27(4):526-32. PubMed ID: 10101148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro.
    Kedderis GL; Carfagna MA; Held SD; Batra R; Murphy JE; Gargas ML
    Toxicol Appl Pharmacol; 1993 Dec; 123(2):274-82. PubMed ID: 8248934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of microsome and hepatocyte scaling factors for in vitro/in vivo extrapolation in the rat and dog.
    Smith R; Jones RD; Ballard PG; Griffiths HH
    Xenobiotica; 2008 Nov; 38(11):1386-98. PubMed ID: 18988082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism, toxicity, and carcinogenicity of trichloroethylene.
    Bruckner JV; Davis BD; Blancato JN
    Crit Rev Toxicol; 1989; 20(1):31-50. PubMed ID: 2673291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro biotransformation of surfactants in fish. Part II--Alcohol ethoxylate (C16EO8) and alcohol ethoxylate sulfate (C14EO2S) to estimate bioconcentration potential.
    Dyer SD; Bernhard MJ; Cowan-Ellsberry C; Perdu-Durand E; Demmerle S; Cravedi JP
    Chemosphere; 2009 Aug; 76(7):989-98. PubMed ID: 19433333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative prediction of the in vivo inhibition of diazepam metabolism by omeprazole using rat liver microsomes and hepatocytes.
    Jones HM; Hallifax D; Houston JB
    Drug Metab Dispos; 2004 May; 32(5):572-80. PubMed ID: 15100181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat.
    Witherow LE; Houston JB
    J Pharmacol Exp Ther; 1999 Jul; 290(1):58-65. PubMed ID: 10381760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.